Revenue of the COVID-19 vaccines market in Indonesia 2021-2028

Revenue of the COVID-19 vaccines market in Indonesia from 2021 to 2022

Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Supplementary notes

Data provided by Statista Market Insights are estimates.

This market covers vaccines against infectious diseases. They help to prevent diseases, usually through active immunization. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B or COVID-19) and bacteria (e.g., typhoid fever or meningococcus) are included.

Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G).

Company examples: Pfizer, GlaxoSmithKline, Merck & Co, Sanofi, Moderna, AstraZeneca

A detailed methodology can be found in the Statista Market Outlook.

Citation formats
Use Statista now: unlimited access to all content

Statistics on " Health in Indonesia "

Other statistics that may interest you Health in Indonesia

Overview

4

Health expenditure

4

Infrastructure

5

Health system

6

Diseases

6

Mortality

4

Digital health

5

COVID-19

5

Further Content: You might find this interesting as well

Use Statista now: unlimited access to all content
Learn more about how Statista can support your business.